1. Home
  2. MTVA vs PMNT Comparison

MTVA vs PMNT Comparison

Compare MTVA & PMNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • PMNT
  • Stock Information
  • Founded
  • MTVA 2014
  • PMNT 1984
  • Country
  • MTVA United States
  • PMNT United Kingdom
  • Employees
  • MTVA N/A
  • PMNT N/A
  • Industry
  • MTVA
  • PMNT
  • Sector
  • MTVA
  • PMNT
  • Exchange
  • MTVA NYSE
  • PMNT NYSE
  • Market Cap
  • MTVA 16.8M
  • PMNT 11.2M
  • IPO Year
  • MTVA N/A
  • PMNT 2024
  • Fundamental
  • Price
  • MTVA $1.74
  • PMNT $0.93
  • Analyst Decision
  • MTVA Strong Buy
  • PMNT Strong Buy
  • Analyst Count
  • MTVA 1
  • PMNT 1
  • Target Price
  • MTVA $12.00
  • PMNT $6.00
  • AVG Volume (30 Days)
  • MTVA 57.9K
  • PMNT 397.8K
  • Earning Date
  • MTVA 03-27-2025
  • PMNT 03-24-2025
  • Dividend Yield
  • MTVA N/A
  • PMNT N/A
  • EPS Growth
  • MTVA N/A
  • PMNT N/A
  • EPS
  • MTVA N/A
  • PMNT N/A
  • Revenue
  • MTVA N/A
  • PMNT $22,375,000.00
  • Revenue This Year
  • MTVA N/A
  • PMNT $3.91
  • Revenue Next Year
  • MTVA N/A
  • PMNT $29.32
  • P/E Ratio
  • MTVA N/A
  • PMNT N/A
  • Revenue Growth
  • MTVA N/A
  • PMNT N/A
  • 52 Week Low
  • MTVA $1.51
  • PMNT $0.66
  • 52 Week High
  • MTVA $6.75
  • PMNT $6.05
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • PMNT N/A
  • Support Level
  • MTVA N/A
  • PMNT N/A
  • Resistance Level
  • MTVA N/A
  • PMNT N/A
  • Average True Range (ATR)
  • MTVA 0.00
  • PMNT 0.00
  • MACD
  • MTVA 0.00
  • PMNT 0.00
  • Stochastic Oscillator
  • MTVA 0.00
  • PMNT 0.00

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About PMNT PERFECT MOMENT LTD

Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.

Share on Social Networks: